Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ImmunityBio, Inc. (IBRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.9700+0.3200 (+6.88%)
At close: 04:00PM EDT
4.9300 -0.04 (-0.80%)
After hours: 04:04PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/24/2022
Current
6/30/20223/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
1.93B1.48B2.23B2.42B3.84B5.57B
Enterprise Value
2.52B1.94B2.56B2.68B4.07B5.81B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
3.79k1.81k2.34k6.04k7.89k9.45k
Price/Book (mrq)
N/AN/AN/AN/AN/AN/A
Enterprise Value/Revenue
4.98k55.35k182.93k6.87k61.67k17.14k
Enterprise Value/EBITDA
-7.49-24.01-28.33-32.10-50.17-71.01

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-53.50%
S&P500 52-Week Change 3-16.03%
52 Week High 310.6890
52 Week Low 32.6000
50-Day Moving Average 34.5276
200-Day Moving Average 35.0010

Share Statistics

Avg Vol (3 month) 31.59M
Avg Vol (10 day) 33.77M
Shares Outstanding 5400.3M
Implied Shares Outstanding 6N/A
Float 897.01M
% Held by Insiders 179.16%
% Held by Institutions 18.68%
Shares Short (Aug 30, 2022) 420.19M
Short Ratio (Aug 30, 2022) 419.33
Short % of Float (Aug 30, 2022) 424.17%
Short % of Shares Outstanding (Aug 30, 2022) 45.04%
Shares Short (prior month Jul 28, 2022) 418.68M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-63,534.26%

Management Effectiveness

Return on Assets (ttm)-71.11%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)505k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-89.70%
Gross Profit (ttm)934k
EBITDA -305.03M
Net Income Avi to Common (ttm)-376.3M
Diluted EPS (ttm)-0.9410
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)82.94M
Total Cash Per Share (mrq)0.21
Total Debt (mrq)664.68M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.31
Book Value Per Share (mrq)-1.05

Cash Flow Statement

Operating Cash Flow (ttm)-310.54M
Levered Free Cash Flow (ttm)-264.43M
Advertisement
Advertisement